• Accueil
• alexia
• Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center

Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center

5 (168) · € 30.50 · En Stock

Scientific Review of Phase I Protocols With Novel Dose-Escalation

Cancers, Free Full-Text

Alexia Iasonos and John O'Quigley - ppt download

Statistics in Oncology Journal of Clinical Oncology

Biostatistics: Members Memorial Sloan Kettering Cancer Center

Sean Devlin - Associate Attending Biostatistician - Memorial Sloan

Incorporating lower grade toxicity information into dose finding

Alexia Iasonos @AlexiaIasonos - Twitter Profile

Efficacy of MEK inhibition in patients with histiocytic neoplasms

Biostatistics: Members Memorial Sloan Kettering Cancer Center

Estimating the dose-toxicity curve from completed Phase I studies